BCM
ENDP

BlueCrest Capital Management’s Endo International plc ENDP Stock Holding History

BlueCrest Capital Management’s Portfolio ENDP Stock Details ENDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-50,000
Closed -$4.49M – 962
2015
Q1 		$4.49M Buy
+50,000
New +$4.18M 0.24% 123

Other funds holding ENDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlueCrest Capital Management's ENDP Position: Q4 2019 in Review

BlueCrest Capital Management sold out of Endo International plc (ENDP) in Q4 2019, closing a stake of 35,468 shares — an estimated $114K sold.

BlueCrest Capital Management first reported a position in ENDP in Q1 2015 and held it in 7 quarters. The position peaked at $4.88M in Q1 2015. 202 funds tracked by Wall St. Rank hold ENDP as of Q4 2019.

  • BlueCrest Capital Management reported no remaining Endo International plc position as of Q4 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 35,468 Endo International plc shares in Q4 2019, an estimated $114K.
  • BlueCrest Capital Management first reported a position in Endo International plc in Q1 2015 and held it in 7 quarters.
  • BlueCrest Capital Management's Endo International plc position peaked at $4.88M in Q1 2015.
  • 202 funds tracked by Wall St. Rank held Endo International plc as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.